A California-based medical device startup pioneering next-generation stroke technology has raised $5 million in seed funding to further develop and commercialize revolutionary technologies for safe cerebrovascular monitoring.
According to the company’s announcement on Thursday, May 23, 2024, DigiTx Partners led the oversubscribed seed round, with a significant contribution from Freeflow Ventures and existing investors.
The latest round of funding will support further validation of the company’s technology and the expansion of its commercial efforts, offering an effective medical device for point-of-care cerebrovascular monitoring.
To date, StrokeDx’s technology has secured nearly $10 million in funding, including an R01 Grant from the National Institutes of Health (NIH). As part of the announcement, David J. Kim, Managing Director of DigiTx Partners, will join StrokeDx’s board.
The startup focuses on developing advanced stroke technologies and software for portable, non-radiating, and non-invasive cerebrovascular monitoring. The company’s innovative approach offers a unique method of surveying stroke using a revolutionary technology developed at the California Institute of Technology to deliver precise results.
The portable devices offer a scalable solution that can help improve stroke outcomes for millions of at-risk individuals, bridging the gaps in healthcare accessibility and equity. With stroke affecting millions globally, leading to long-term disability or mortality, early detection, and close monitoring can improve survival rates as well as the quality of life of those affected.
